Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

被引:4
作者
Lete, Inaki [1 ,2 ]
Martinez, Ainara [1 ]
Lasaga, Irene [1 ]
Centurion, Eva [1 ]
Vesga, Amaia [1 ]
机构
[1] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Vitoria, Spain
[2] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Txagorritxu Campus, Vitoria 01009, Spain
关键词
Polycystic ovary syndrome; inositol; MYO/DCI ratio; HUMAN THECAL CELLS; GROWTH-FACTOR-I; FOLLICULAR-FLUID; OOCYTE QUALITY; THERAPEUTIC APPROACH; ANDROGEN PRODUCTION; GENE-PRODUCTS; IGF-II; MYOINOSITOL; WOMEN;
D O I
10.1080/09513590.2023.2301554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction
    Papaleo, Enrico
    Unfer, Vittorio
    Baillargeon, Jean-Patrice
    De Santis, Lucia
    Fusi, Francesco
    Brigante, Claudio
    Marelli, Guido
    Cino, Ilaria
    Redaelli, Anna
    Ferrari, Augusto
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (12) : 700 - 703
  • [42] The Role of Myo-Inositol in the regulation of female hormones and Polycystic Ovary Syndrome
    Martinez-Loria, Hazel Johanna
    Vargas-Zuniga, Lester Fabian
    Gonzalez-Vargas, Joshua Andrey
    Cordero-Robles, Kristel Mariana
    Urrea-Mayorga, Maria Jose
    TECNOLOGIA EN MARCHA, 2024, 37 (04): : 133 - 140
  • [43] The use of D-chiro-Inositol in clinical practice
    Gambioli, R.
    Forte, G.
    Aragona, C.
    Bevilacqua, A.
    Bizzarri, M.
    Unfer, V
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 438 - 446
  • [44] Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
    Merviel, Philippe
    James, Pandora
    Bouee, Sarah
    Le Guillou, Mathilde
    Rince, Camille
    Nachtergaele, Charlotte
    Kerlan, Veronique
    REPRODUCTIVE HEALTH, 2021, 18 (01)
  • [45] Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
    Philippe Merviel
    Pandora James
    Sarah Bouée
    Mathilde Le Guillou
    Camille Rince
    Charlotte Nachtergaele
    Véronique Kerlan
    Reproductive Health, 18
  • [46] Effectiveness, Tolerability and Safety of a Compound Based on D-chiro-inositol plus Myo-inositol, Melatonin, Folic Acid, and Vitamin D in Patients with Menstrual Cycle Disorders
    Gonzalez, Silvia P.
    Rubio, Maria del Mar
    Losa, Helena
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (02)
  • [47] Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol
    Antonio Simone Laganà
    Luisa Barbaro
    Alfonsa Pizzo
    Archives of Gynecology and Obstetrics, 2015, 291 : 1181 - 1186
  • [48] Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol
    Lagana, Antonio Simone
    Barbaro, Luisa
    Pizzo, Alfonsa
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (05) : 1181 - 1186
  • [49] Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?
    Mertoglu, Cuma
    Gunay, Murat
    Gul, Vahdet
    Kulhan, Mehmet
    Aktas, Mehmet
    Coban, Taha Abdulkadir
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (05) : 418 - 421
  • [50] The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
    Pustotina, Olga
    Myers, Samuel H.
    Unfer, Vittorio
    Rasulova, Irina
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (02) : 131 - 139